Antidiabetic effect of morinda citrifolia (Noni) fermented by cheonggukjang in KK-A y diabetic mice

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Lee, So Young ^a   Park, So Lim ^a   Hwang, Jin Taek ^a   Yi, Sung Hun ^a   Nam, Young Do ^a   Lim, Seong Il ^a  

^a Korea Food Research Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MORINDA CITRIFOLIA EXTRACT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CHEONGGUKJANG; CONTROLLED STUDY; FERMENTATION; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; INSULIN SENSITIVITY; MALE; MORINDA CITRIFOLIA; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; SOYBEAN; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84866065399     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/163280     Document Type: Article

References (38)

1. Alberti K. G. M. M., Zimmet P. Z., Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1sdiagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine 1998 15 7 539 553 2-s2.0-0031851293 10.1002/(SICI)1096- 9136(199807)15:7539::AID-DIA668>3.0.CO;2-S (Pubitemid 28319935)
2. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 2004 27 supplement 1 S5 S10 2-s2.0-1042302780
3. Lin Y., Sun Z., Current views on type 2 diabetes. Journal of Endocrinology 2010 204 1 1 11 2-s2.0-73949146152 10.1677/JOE-09-0260
4. Chattopadhyay R. R., A comparative evaluation of some blood sugar lowering agents of plant origin. Journal of Ethnopharmacology 1999 67 3 367 372 2-s2.0-0032888513 10.1016/S0378-8741(99)00095-1 (Pubitemid 29469749)
5. Miura T., Ueda N., Yamada K., Fukushima M., Ishida T., Kaneko T., Matsuyama F., Seino Y., Antidiabetic effects of corosolic acid in KK-Ay diabetic mice. Biological and Pharmaceutical Bulletin 2006 29 3 585 587 2-s2.0-33645224036 10.1248/bpb.29.585
6. Baskaran K., Ahamath B. K., Shanmugasundaram K. R., Shanmugasundaram E. R. B., Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. Journal of Ethnopharmacology 1990 30 3 295 305 2-s2.0-0025087317 (Pubitemid 20343332)
7. Iizuka Y., Sakurai E., Tanaka Y., Antidiabetic effect of folium mori in GK rats. Yakugaku Zasshi 2001 121 5 365 369 2-s2.0-0035022739 10.1248/yakushi.121.365 (Pubitemid 32440587)
8. Oh W. K., Lee C. H., Lee M. S., Bae E. Y., Sohn C. B., Oh H., Kim B. Y., Ahn J. S., Antidiabetic effects of extracts from Psidium guajava. Journal of Ethnopharmacology 2005 96 3 411 415 2-s2.0-21644468952 10.1016/j.jep.2004.09.041 (Pubitemid 41556591)
9. Hirazumi A., Furusawa E., Chou S. C., Hokama Y., Immunomodulation contributes to the anticancer activity of Morinda citrifolia (Noni) fruit juice. Proceedings of the Western Pharmacology Society 1996 39 7 9 2-s2.0-0029804532 (Pubitemid 26341767)
10. Nayak B. S., Sandiford S., Maxwell A., Evaluation of the wound-healing activity of ethanolic extract of Morinda citrifolia L. leaf. Evidence-Based Complementary and Alternative Medicine 2009 6 3 351 356 2-s2.0-68849098379 10.1093/ecam/nem127
11. Wang M. Y., Su C., Cancer preventive effect of Morinda citrifolia (Noni). Annals of the New York Academy of Sciences 2001 952 161 168 2-s2.0-0035680416 (Pubitemid 34060019)
12. Singh S. K., Rai P. K., Jaiswal D., Watal G., Evidence-based critical evaluation of glycemic potential of Cynodon dactylon. Evidence-Based Complementary and Alternative Medicine 2008 5 4 415 420 2-s2.0-56749183815 10.1093/ecam/nem044
13. Nayak B. S., Marshall J. R., Isitor G., Adogwa A., Hypoglycemic and hepatoprotective activity of fermented fruit juice of Morinda citrifolia (noni) in diabetic rats. Evidence-Based Complementary and Alternative Medicine 2011 2011 5 2-s2.0-78349267222 10.1155/2011/875293 875293
14. Srinivasan K., Ramarao P., Animal models in type 2 diabetes research: an overview. Indian Journal of Medical Research 2007 125 3 451 472 2-s2.0-34249279490 (Pubitemid 46805458)
15. Lim S. I., Lee B. Y., Anti-diabetic effect of material fermented using rice bran and soybean as the main ingredient by Bacillus sp. Journal of Korean Society Application Biological Chemistry 2010 53 2 222 229 2-s2.0-79954472986 10.3839/jksabc.2010.035
16. Lim S. I., Cho C. W., Choi U. K., Kim Y. C., Antioxidant activity and ginsenoside pattern of fermented white ginseng. Journal of Ginseng Research 2010 34 3 168 174 2-s2.0-79951791059 10.5142/jgr.2010.34.3.168
17. Matthews D. R., Hosker J. P., Rudenski A. S., Homeostasis model assessment: insulin resistance and β -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 7 412 419 2-s2.0-0021813187 (Pubitemid 15018832)
18. Zhang W. Y., Lee J. J., Kim I. S., Kim Y., Park J. S., Myung C. S., 7-0-methylaromadendrin stimulates glucose uptake and improves insulin resistance in vitro. Biological and Pharmaceutical Bulletin 2010 33 9 1494 1499 2-s2.0-77957571019 10.1248/bpb.33.1494
19. Saito T., Abe D., Sekiya K., Sakuranetin induces adipogenesis of 3T3-L1 cells through enhanced expression of PPAR γ 2. Biochemical and Biophysical Research Communications 2008 372 4 835 839 2-s2.0-45449088491 10.1016/j.bbrc.2008.05.146
20. Vessal M., Hemmati M., Vasei M., Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comparative Biochemistry and Physiology C 2003 135 3 357 364 2-s2.0-0041589462 10.1016/S1532-0456(03)00140-6 (Pubitemid 36962949)
21. Shoelson S. E., Lee J., Goldfine A. B., Inflammation and insulin resistance. Journal of Clinical Investigation 2006 116 7 1793 1801 2-s2.0-33745861300 10.1172/JCI29069
22. Okusada K., Nakamoto K., Nishida M., Fujita-Hamabe W., Kamiya K., Mizushina Y., Satake T., Tokuyama S., The antinociceptive and anti-inflammatory action of the CHCl 3-soluble phase and its main active component, damnacanthal, isolated from the root of Morinda citrifolia. Biological and Pharmaceutical Bulletin 2011 34 1 103 107 2-s2.0-78951487273 10.1248/bpb.34.103
23. Su B. N., Pawlus A. D., Jung H. A., Keller W. J., McLaughlin J. L., Kinghorn A. D., Chemical constituents of the fruits of Morinda citrifolia (Noni) and their antioxidant activity. Journal of Natural Products 2005 68 4 592 595 2-s2.0-17844393868 10.1021/np0495985 (Pubitemid 40586327)
24. Pawlus A. D., Su B. N., Keller W. J., Kinghorn A. D., An anthraquinone with potent quinone reductase-inducing activity and other constituents of the fruits of Morinda citrifolia (Noni). Journal of Natural Products 2005 68 12 1720 1722 2-s2.0-30544455292 10.1021/np050383k (Pubitemid 43082641)
25. Hardie D. G., Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 2003 144 12 5179 5183 2-s2.0-0344081177 10.1210/en.2003-0982 (Pubitemid 37476044)
26. Fryer L. G. D., Parbu-Patel A., Carling D., The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. Journal of Biological Chemistry 2002 277 28 25226 25232 2-s2.0-0037067666 10.1074/jbc.M202489200 (Pubitemid 34951829)
27. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M. F., Goodyear L. J., Moller D. E., Role of AMP-activated protein kinase in mechanism of metformin action. Journal of Clinical Investigation 2001 108 8 1167 1174 2-s2.0-0034773404 10.1172/JCI200113505 (Pubitemid 32995375)
28. Zang M., Zuccollo A., Hou X., Nagata D., Walsh K., Herscovitz H., Brecher P., Ruderman N. B., Cohen R. A., AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. Journal of Biological Chemistry 2004 279 46 47898 47905 2-s2.0-9144271181 10.1074/jbc.M408149200 (Pubitemid 39540941)
29. Cuthbertson D. J., Babraj J. A., Mustard K. J. W., Towler M. C., Green K. A., Wackerhage H., Leese G. P., Baar K., Thomason-Hughes M., Sutherland C., Hardie D. G., Rennie M. J., 5-Aminoimidazole-4-carboxamide 1- β -D-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men. Diabetes 2007 56 8 2078 2084 2-s2.0-34547591785 10.2337/db06-1716 (Pubitemid 47195820)
30. Lee M. S., Hwang J. T., Kim S. H., Yoon S., Kim M. S., Yang H. J., Kwon D. Y., Ginsenoside Rc, an active component of Panax ginseng, stimulates glucose uptake in C2C12 myotubes through an AMPK-dependent mechanism. Journal of Ethnopharmacology 2010 127 3 771 776 2-s2.0-76149144996 10.1016/j.jep.2009.11. 022
31. Benhaddou-Andaloussi A., Martineau L. C., Vallerand D., Haddad Y., Afshar A., Settaf A., Haddad P. S., Multiple molecular targets underlie the antidiabetic effect of Nigella sativa seed extract in skeletal muscle, adipocyte and liver cells. Diabetes, Obesity and Metabolism 2010 12 2 148 167 2-s2.0-73349091554 10.1111/j.1463-1326.2009.01131.x
32. Leiter L. A., Can thiazolidinediones delay disease progression in type 2 diabetes? Current Medical Research and Opinion 2006 22 6 1193 1201 2-s2.0-33745700036 10.1185/030079906X112507 (Pubitemid 44000739)
33. Spiegelman B. M., PPAR- γ: adipogenic regulator and thiazolidinedione receptor. Diabetes 1998 47 4 507 514 2-s2.0-0031898610 10.2337/diabetes.47.4.507 (Pubitemid 28160438)
34. Cho M. C., Lee K., Paik S. G., Yoon D. Y., Peroxisome proliferators-activated receptor (PPAR) modulators and metabolic disorders. PPAR Research 2008 2008 14 2-s2.0-47349107995 10.1155/2008/679137 679137 (Pubitemid 352000619)
35. Girard J., Mechanisms of action of thiazolidinediones. Diabetes and Metabolism 2001 27 2 271 278 2-s2.0-0035040960 (Pubitemid 32405575)
36. Kwon D. Y., Kim D. S., Yang H. J., Park S., The lignan-rich fractions of Fructus Schisandrae improve insulin sensitivity via the PPAR- γ pathways in in vitro and in vivo studies. Journal of Ethnopharmacology 2011 135 2 455 462 2-s2.0-79955682914 10.1016/j.jep.2011.03.037
37. Nagashima K., Lopez C., Donovan D., Ngai C., Fontanez N., Bensadoun A., Fruchart-Najib J., Holleran S., Cohn J. S., Ramakrishnan R., Ginsberg H. N., Effects of the PPAR γ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus. Journal of Clinical Investigation 2005 115 5 1323 1332 2-s2.0-20944439286 10.1172/JCI200523219 (Pubitemid 40629052)
38. Freed M. I., Ratner R., Marcovina S. M., Kreider M. M., Biswas N., Cohen B. R., Brunzell J. D., Effects of rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities in type 2 diabetes mellitus. American Journal of Cardiology 2002 90 9 947 952 2-s2.0-0036830104 10.1016/S0002-9149(02)02659-0 (Pubitemid 35232617)